Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dan Thayer
AddedMar 31, 2024
UpdatedMay 31, 2026
Dan Thayer

Dan Thayer

Founder, SafeShot Technologies

CrunchbaseLinkedIn

Dan Thayer's Career

SafeShot Technologies
SafeShot Technologies

Mission Viejo, CA, US

Founder
Credence MedSystems
Credence MedSystems

Menlo Park, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dan Thayer's Career

SafeShot Technologies
SafeShot Technologies
Series A$9M52011Mission Viejo, CA, US
Founder

Similar to SafeShot Technologies

SafePath MedicalSafePath MedicalAmesbury, MA, USMedical Devicesest. 2010SafePath MedicalAmesbury, MA, US · est. 2010

SafePath Medical: Pioneering safety technology for healthcare workers since 2010.

Pre-Seed · $1.5M11
EquashieldEquashieldPort Washington, NY, USMedical Devicesest. 2009EquashieldPort Washington, NY, US · est. 2009

NY-based Equashield manufactures medical devices for safe handling of hazardous drugs.

Late Stage Private · $300M200
Retractable TechnologiesRetractable TechnologiesLittle Elm, TX, USSafety Needlesest. 1994Retractable TechnologiesLittle Elm, TX, US · est. 1994

US-based Retractable Technologies designs and manufactures safety needle devices, preventing injuries and reuse.

Public198
Credence MedSystems
Credence MedSystems
Series D$102.4M132011Menlo Park, CA, US
Founder

Leadership at Credence MedSystems

Norman GordonNorman GordonBoard Member
Jeff ShanleyJeff ShanleyCEO

Similar to Credence MedSystems

Control Delivery SystemsControl Delivery SystemsWatertown, MA, USBiotechnologyControl Delivery SystemsWatertown, MA, US

Control Delivery Systems: A leading innovator in the biotechnology industry.

Series C · $34.5M50
Inson Medical SystemsInson Medical SystemsBellevue, WA, USDrug Deliveryest. 2007Inson Medical SystemsBellevue, WA, US · est. 2007

Inson Medical Systems develops and commercializes innovative drug delivery solutions, based in Bellevue, WA since 2007.

Public · $642.5k2
GenixusGenixusKannapolis, NC, USMedical Devicesest. 2019GenixusKannapolis, NC, US · est. 2019

Genixus: Advanced manufacturer of ready-to-use, error-proof medication delivery systems for acute and critical care.

Series B · $20M20
Cam MedCam MedWest Newton, MA, USHealthcare Equipment, Medical Devicesest. 2014Cam MedWest Newton, MA, US · est. 2014

Cam-Med, Inc.: A leading US provider of innovative healthcare equipment and medical devices.

Seed · $3M50

Dan Thayer's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Dan Thayer

Alex BabkinAlex BabkinCo-Founder · CryoMedixDan DubinDan DubinBoard Member · Leerink PartnersJay RindenauJay RindenauCo-Founder · MediSensUday DevanaboyinaUday DevanaboyinaCo-Founder · G-Tech MedicalGeoff ThropeGeoff ThropeBoard Member · NDI Medical